CHWY vs SPB: How Chewy and Spectrum Brands Holdings, Inc. Compare (2026)

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CHWY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CHWY and SPB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CHWY and SPB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Chewy is the largest pure-play online retailer of pet products in the United States, selling pet food, treats, supplies, prescription medications, and other essentials, plus a growing set of pet-health services. The core of the model is Autoship, an auto-replenishment subscription that schedules recurring deliveries of food and supplies; Autoship accounts for roughly 83% of net sales, which gives Chewy unusually predictable, repeat-purchase revenue for a retailer. The company makes most of its money on product sales at retail-style gross margins, but it is steadily mixing in higher-margin revenue from Chewy Pharmacy, sponsored ads through its Chewy Ads retail-media network, and veterinary care. In fiscal 2025 (the year ended February 1, 2026) Chewy reported net sales of about $12.60 billion, up 6.2% (roughly 8.3% on a comparable 52-week basis), with around 21.3 million active customers and net sales per active customer near $600.

Full CHWY guide

Spectrum Brands Holdings owns and operates consumer brands across three reporting segments. Global Pet Care is the largest and includes Tetra and Marineland in aquatics plus FURminator, Nature's Miracle, DreamBone and 8-in-1 in companion animal. Home & Garden sells household pest and lawn control under Spectracide, Cutter, Hot Shot and Black Flag, a business that swings with spring weather and retailer order timing. Home & Personal Care covers small kitchen and grooming appliances under Remington, George Foreman and Russell Hobbs. The company does not own premium category leaders in most of these aisles. It owns the value and mid-tier positions, sold largely through Walmart, Amazon, Home Depot, Lowe's and other big-box retail, which makes shelf space and retailer inventory decisions a bigger swing factor than brand pricing power.

Full SPB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CHWY drivers: Autoship makes the revenue sticky; Higher-margin businesses are the profit lever.
• SPB drivers: Pet care as the growth and margin anchor; Home & Garden operating leverage when the weather cooperates.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. For SPB, spectrum's brands sit largely in value and mid-tier price points sold through a handful of very large retailers, so a shelf-reset decision at Walmart or a retailer inventory correction can move a quarter more than consumer demand does.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CHWY if you believe its drivers more; SPB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CHWY and SPB guides.

CHWY. Chewy is best read as a profitable but low-margin retailer that is trying to mix in higher-margin revenue, so watch the trend in gross margin and adjusted EBITDA margin more than headline sales growth. Because product sales dominate, net margins are thin (low single digits), and free cash flow is often a cleaner gauge of health than GAAP net income, which can be swung by share-based compensation and tax items. Active-customer growth and net sales per active customer show whether the base is expanding or just spending more. Since Chewy pays no dividend and reinvests in pharmacy, ads, and vet care while buying back stock, the valuation hinges on whether those higher-margin businesses scale fast enough to justify a growth multiple.

SPB. The multiple looks ordinary for a consumer staples name until you notice the share count. About 23 million shares outstanding against roughly $2.8 billion of revenue means the enterprise trades at a fraction of one times sales, while the earnings multiple sits in the high teens because margins are thin at the consolidated level. Guidance for fiscal 2026 calls for net sales flat to up low single digits, adjusted EBITDA up low to mid single digits, and roughly 50% conversion of adjusted EBITDA into adjusted free cash flow. The stock has run from a 52-week low near $50 to about $88, close to its $92 high, so the discount that attracted value buyers a year ago is materially narrower.

Headline figures (approximate, FY2025 results (year ended February 1, 2026) and Q1 FY2026 (ended May 3, 2026)): CHWY shows fy2025 net sales About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis), fy2025 net income About $222.8 million, fy2025 adjusted ebitda About $719 million, up roughly 26%, fy2025 free cash flow Record of about $562 million; SPB shows revenue (ttm) ~$2.82 billion, down ~3.8% year over year, fiscal q2 2026 net sales ~$709 million, up ~4.9% reported and ~1.5% organic, fiscal q2 2026 adjusted ebitda ~$84 million, up ~$12.7 million year over year, net income / eps (ttm) ~$126 million and ~$5.24 per share.

CHWY and SPB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CHWY and SPB exposure against your real portfolio. It is not an investment adviser.